Stock CRVO CERVOMED INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart CervoMed Inc.

Equities

CRVO

US15713L1098

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-20 pm EDT 		5-day change 1st Jan Change
21.4 USD +10.14% Intraday chart for CervoMed Inc. +8.30% +180.47%
Jun. 11 CervoMed Inc. Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodies CI
May. 29 JonesTrading Starts CervoMed With Buy Rating, $70 Price Target MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CERVOMED INC.
Bio Therapeutic Drugs
+10.14%+8.30%+180.47% - - 160M
Bearish
Bullish
Bullish
  1. Stock Market
  2. Equities
  3. CRVO Stock
  4. Charts CervoMed Inc.
  5. Relative Strength Chart